The McEwen Investment Report
David McEwen
Head Researcher
Professional Journalist Turned Investment Analyst
After writing for The Financial Times, Reuters News Service, National Business Review David turned his talents towards investment analysing. Over 30 years of watching the markets David offers timely and easy-to-understand commentary on shares that he classifies through the use of 9 unique key criteria.
The McEwen Investment Report
Decades of success
The McEwen Investment Report was established in New Zealand in 1998, and has since provided readers with accurate, timely and effective guidance to the share market. Growing to become a global title, offering fresh thinking and analysis of shares on the NZ, Australian, UK, and US stock markets. The newsletter offers easy-to-understand commentary on shares to buy, hold and sell. Using David McEwen's unique 9 Key Criteria we find financially sound businesses that are temporarily undervalued by other investors.
This has proven to be a low-risk strategy that to date has delivered returns that are substantially above the overall market.
The report is refreshingly free of jargon and complicated calculations, making it easy to read and understand, while every company profiled comes with a firm trading recommendation.
Information That Pays
16.49% In 3 Days!
Pro Medicus
Tip given in The McEwen Platinum Club.
David McEwen advised the members of the McEwen Platinum Club to purchase Pro Medicus stocks on Thursday, the 6th of August. Three days later, he advised them to sell for a handsome 16.49% profit!
25.40% In 5 Weeks!
Northern Star Resources
Tip given in The McEwen Investment Report.
On Thursday the 20th of June, David advised our members to invest in Northern Star Resources. Five weeks later, he advised they sell. Our readers made 25.40% in just 5 weeks!
Checkout some of Dave's latest updates!
Fisher and Paykel Healthcare (NZ: FPH) hit its high point of $37.68 in September and is currently slowly making a recovery. It was, however, unable to break its previous high point before falling. 📉Today it has already dropped 2%, showing that the #shares may have topped out https://t.co/pgCXzEL4dd
Webjet (AU:WEB) has seen its #share #price bounce up by 4% today after the company said that it was seeing a lot of pent up demand for #travel services. Now that progress is being made rapidly towards a Covid-19 vaccine, #international travel may well bounce back next year https://t.co/vCWQ1NKS3l
Sonic Healthcare (AU: #SHL) has recovered its mojo in recent weeks after a dip and is close to a new yearly high.🙌 It is ramping up its #coronavirus #testing efforts in the Northern hemisphere so it looks poised to have a strong second half of its #financial year. https://t.co/xT0osR1AcQ
A2 Milk ( #NZ: ATM) #shares have certainly fallen out of bed in recent days! 🥛
In the past, however, the shares have had a lot of support at around $15 - maybe the time to pick up a bargain could be approaching?🤔 https://t.co/y3ZASkO7Ab
Save up to 50% on a subscription to the McEwen Investment Report!
Receive a money back guarantee on any unsent issues.
Join The McEwen Team!
Get To Know Us!
$74.90$0.00McEwen Investment Report
$99.00 – $1,200.00McEwen Platinum Club
$4,450.50$2,249.90
Great Info & Fantastic Insights
5/5
My average buy price for A2 Milk, which you recommended, is 66c compared with the current price of over $12.00. I still have 5715 shares and current gains total $87,500.00. Over 46 yrs of fiddling about on the NZ market this is by far the best return.
- A McCullough, Christchurch
Good Picks
4.5/5
I made 30% in two months from your pick of Evraz. I don’t know how you find such shares that others have never even heard of, but I am very pleased that you do.
- L Jollands, Auckland
